Clinical depression screening

Jump to navigation Jump to search

Clinical Depression Microchapters

Home

Patient Information

Major Depressive Disorder (Patient Information)

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Clinical Depression from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Substance/Medication-induced Depressive Disorder

Depressive Disorder due to a Medical Condition

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Psychotherapy

ECT

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Follow-up

Follow-Up

Case Studies

Case #1

Clinical depression screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Clinical depression screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Clinical depression screening

CDC on Clinical depression screening

Clinical depression screening in the news

Blogs on Clinical depression screening

Directions to Hospitals Treating Clinical depression

Risk calculators and risk factors for Clinical depression screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

According to the U.S. Preventive Services Task Force (USPSTF), screening for major depressive disorder is recommended in children and adolescents 12 to 18 years of age, in older adults, and in pregnant women (at least once during pregnancy and again 4-8 weeks after delivery).

Screening

  • The U.S. Preventive Services Task Force (USPSTF) does not recommend routine screening for major depressive disorder ([MDD]) in children 7 to 11 years of age.
  • The USPSTF recommends screening for MDD in children and adolescents 12 to 18 years of age.
  • The U.S. Preventive Services Task Force (USPSTF) and American Academy of Family Physicians recommend screening for MDD in the general adult population.
  • The USPSTF, American Academy of Family Physicians, American Academy of Pediatrics, and American College of Obstetricians and Gynecologists recommend screening all postpartum women for depression.
  • The USPSTF recommends that all pregnant women should be screened for depression at least once during the perinatal period. It recommends screening at least once during pregnancy and again 4-8 weeks after delivery.
  • In older adults, instruments such as PHQ-2, PHQ-9, Cornell Scale for Depression in Dementia, or Geriatric Depression Scale are appropriate screening tools.
  • When any of the screening instruments is positive for possible depression, the diagnosis needs to be confirmed according to the criteria from the Diagnostic and Statistical Manual of Mental Disorders, 5th ed.

References

Template:WikiDoc Sources